Daniel Lima Bellan

Daniel Lima Bellan

Auto-generated profile, based on publicly available information

Daniel Lima Bellan

Department of Cellular Biology, UFPR, Curitiba, PR, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
HBHeloise Ribeiro de Barros
Heloise Ribeiro de Barros
MCMateus Borba Cardoso
Mateus Borba Cardoso
COCarolina Camargo de Oliveira
Carolina Camargo de Oliveira
CFCélia Regina Cavichiolo Franco
Célia Regina Cavichiolo Franco
DBDaniel de Lima Belan
Daniel de Lima Belan
IVIzabel Cristina Riegel Vidotti
Izabel Cristina Riegel Vidotti
For the safe use of nanoparticles, especially in the biomedical field, their stability in different environments and the prevention of binding to the component organisms, which could lead to nanoparticle aggregation, is indispensable. Herein, we present a simple, efficient and biologically based method to obtain small gum arabic (GA)-stabilized gold nanoparticles (GA-AuNPs) with remarkable stability in physiological pHs. The in vitro stability tests in intestinal (pH 6.8) and gastric (pH 1.2) simulated pHs revealed that GA-AuNPs exhibit a surprisingly high stability even near the zero zeta potential. When subjected to GA-AuNPs, changes in the viability, proliferation and morphology were selectively induced in the B16-F10 melanoma cell line, whereas no alterations in the macrophage cell line, RAW 264.7, or in the fibroblast cell line, BALB/3T3, were observed at the same concentrations. Therefore, considering the remarkable stability and selective effect on cell lines, we show that GA-AuNPs exhibit properties that could provide a future alternative for melanoma treatment.

1 December 2019 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RORuberney S. Oliveira
Ruberney S. Oliveira
SBStellee Marcela Petris Biscaia
Stellee Marcela Petris Biscaia
DBDaniel L. Bellan
Daniel L. Bellan
SVSthefany R.F. Viana
Sthefany R.F. Viana
Maria Carolina Bezerra Di MedeirosMaria Carolina Bezerra Di Medeiros
Maria Carolina Bezerra Di Medeiros
ECElaine R. Carbonero
Elaine R. Carbonero

1 December 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
SBS.M.P. Biscaia
S.M.P. Biscaia
ECE.R. Carbonero
E.R. Carbonero
DBD.L. Bellan
D.L. Bellan
BBB.S. Borges
B.S. Borges
CCC.R. Costa
C.R. Costa
ETEdvaldo Trindade
Edvaldo Trindade

21 December 2018 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MMMaxsuell Lucas Mendes Marques
Maxsuell Lucas Mendes Marques
FPFernando Bastos Presa
Fernando Bastos Presa
RVRony Viana
Rony Viana
MCMariana Santana Santos Pereira Costa
Mariana Santana Santos Pereira Costa
MAMonica Oliveira Rocha Amorim
Monica Oliveira Rocha Amorim
Hugo Alexandre Oliveira RochaHugo Alexandre Oliveira Rocha
Hugo Alexandre Oliveira Rocha
In this study, sulfated polysaccharide-rich extracts were isolated from 22 tropical seaweeds (4 red, 11 brown, and 7 green) found in northeastern Brazil, and evaluated for the role of anticoagulant agents. Fifteen of the extracts showed anticoagulant activity, including all the extracts from green seaweeds. Udotea flabellum (a green seaweed) extract was the most potent, requiring an amount of only 3 µg to double the plasma coagulation time in the activated partial thromboplastin time test. A similar result was obtained with 1 µg of heparin. Two sulfated homogalactans with anticoagulant activity, F-I (130 kDa) and F-II (75 kDa), were isolated from this extract using several bio-guided purification steps. Their anticoagulant activity, as well as properties related to antitumor activity (anti-proliferative, anti-adhesive, and anti-migratory), were accessed. Their anticoagulant activities were close to that of heparin. We found that F-I and F-II (0.5–10 μg/mL) were not able to directly inhibit thrombin. In the presence of anti-thrombin, F-I (0.5 μg/mL) was more effective than heparin (0.5 μg/mL) in inhibiting thrombin, while F-II showed similar effects as heparin. F-I and F-II also inhibited B16-F10 (murine melanoma cells) adhesion, migration, and proliferation on a fibronectin-coated surface, but not on laminin- or collagen I-coated surfaces. Except for the antiproliferative activity, the other effects of F-I and F-II were eliminated upon their desulfation (~50%), indicating that the degree of sulfation is not as important for F-I and F-II anti-proliferative activity as the sulfation position. Taken together, the results provide strong evidence for the potential utility of sulfated galactans from U. flabellum, making these compounds an interesting option for future investigations that aim to design new anticoagulant/antitumor agents.


1 December 2020 in Chemosphere
Verified
Journal Article
Closed access
PBPatricia Manuitt Brito
Patricia Manuitt Brito
SBStellee Marcela Petris Biscaia
Stellee Marcela Petris Biscaia
TSTugstenio Lima de Souza
Tugstenio Lima de Souza
ARAmandia Batscheuer Ramos
Amandia Batscheuer Ramos
JLJoelma Leão-Buchir
Joelma Leão-Buchir
CRCiro Alberto Oliveira Ribeiro
Ciro Alberto Oliveira Ribeiro